These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 237832)

  • 1. Bivalent hapten-antibody interactions--III. Formation of an unusual polymer by IGA (MOPC 315) upon binding a bivalent hapten.
    Wilder RL; Green G; Schumaker VN
    Immunochemistry; 1975 Jan; 12(1):54-60. PubMed ID: 237832
    [No Abstract]   [Full Text] [Related]  

  • 2. A functional examination of hapten-binding derivatives from a murine myeloma protein with immunoglobulin features.
    Merz DC; Litman GW; Good RA
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1940-4. PubMed ID: 4525470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalent hapten-antibody interactions--1. A comparison of water soluble and water insoluble bivalent haptens.
    Wilder RL; Green G; Schumaker VN
    Immunochemistry; 1975 Jan; 12(1):39-47. PubMed ID: 1140818
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloma proteins with anti-hapten antibody activity: epsilon-2,4-dinitrophenyl lysine binding by the protein produced by mouse plasmacytoma MOPC-460.
    Jaffe BM; Eisen HN; Simms ES; Potter M
    J Immunol; 1969 Oct; 103(4):872-4. PubMed ID: 5349739
    [No Abstract]   [Full Text] [Related]  

  • 5. Symmetry of binding sites of a mouse IgA myeloma protein (MOPC 315).
    Eisenberg R; Plotz P
    Biochemistry; 1978 Oct; 17(22):4801-7. PubMed ID: 569494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resonance Raman-spectroscopic studies of the hapten features involved in the binding of 2,4-dinitrophenyl haptens by the mouse myeloma proteins MOPC 315 and MOPC 460.
    Kumar K; Phelps DJ; Carey PR; Young NM
    Biochem J; 1978 Nov; 175(2):727-35. PubMed ID: 743221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalent hapten-antibody interactions--11. Bivalent haptens as probes of combining site depth.
    Wilder RL; Green G; Schumaker VN
    Immunochemistry; 1975 Jan; 12(1):49-54. PubMed ID: 1140819
    [No Abstract]   [Full Text] [Related]  

  • 8. A monoclonal antiidiotypic antibody to MOPC 315 IgA inhibits the growth of MOPC 315 myeloma cells in vitro.
    Mahony J; Bose A; Cowdrey D; Nusair T; Lei M; Harris J; Marks A; Baumal R
    J Immunol; 1981 Jan; 126(1):113-7. PubMed ID: 7451962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution from subunits of the hapten binding sites and idiotypic determinants of mouse anti-phosphorylcholine myeloma proteins.
    Sher A; Lord E; Cohn M
    J Immunol; 1971 Nov; 107(5):1226-34. PubMed ID: 4107359
    [No Abstract]   [Full Text] [Related]  

  • 10. Extrinsic Cotton effects characteristic of specific hapten-antibody interactions.
    Glaser M; Singer SJ
    Proc Natl Acad Sci U S A; 1971 Oct; 68(10):2477-9. PubMed ID: 5289880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of hapten-antibody interaction. Studies on a myeloma protein with anti-2,4-dinitrophenyl specificity.
    Pecht I; Givol D; Sela M
    J Mol Biol; 1972 Jul; 68(2):241-7. PubMed ID: 5069790
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic evidence for hapten-induced conformational transition in immunoglobin MOPC 460.
    Lancet D; Pecht I
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3549-53. PubMed ID: 1068466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,4-dinitrophenyl-hapten specific hemolytic plaque-in-gel formation by mouse myeloma (MOPC-315) cells.
    Yamada H; Yamada A; Hollander VP
    J Immunol; 1970 Jan; 104(1):251-5. PubMed ID: 4904002
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnetic resonance studies of the binding site interactions between 19F-labeled nitrophenyl haptens and specific mouse myeloma immunoglobulin MOPC-315.
    Kooistra DA; Richards JH
    Biochemistry; 1978 Jan; 17(2):345-51. PubMed ID: 619995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A search for hapten-binding mouse plasmacytoma proteins.
    Mäkela O; Kaartinen M; Karjalainen K; Morse HC; Weigert M; Potter M
    Eur J Immunol; 1979 Feb; 9(2):125-9. PubMed ID: 436927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular dichroism of hapten-antibody complexes: studies of tryptophanyl residue involvement in the antibody combining sites of MOPC-315 protein heavy and light chain subunits, reconstituted MOPC-315 protein and its FV-fragment.
    Freed RM; Rockey JH; Davis RC
    Immunochemistry; 1976 Jun; 13(6):509-15. PubMed ID: 820635
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization with hapten of the Fab' fragment from a mouse IgA myeloma protein with antidinitrophenyl activity.
    Inbar D; Rotman M; Givol D
    J Biol Chem; 1971 Oct; 246(20):6272-5. PubMed ID: 4942559
    [No Abstract]   [Full Text] [Related]  

  • 19. Affinity constant of anti-DNP secretory IgA.
    Comoglio PM
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(11):739-43. PubMed ID: 4944671
    [No Abstract]   [Full Text] [Related]  

  • 20. Hapten binding studies on mouse IgA myeloma proteins with antibody activity.
    Sher A; Tarikas H
    J Immunol; 1971 May; 106(5):1227-33. PubMed ID: 4995750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.